Recent preclinical studies in the animal models of pancreatic cancer and clear cell renal cell carcinoma have suggested that the upregulation of CcO activity, and thereby OXPHOS, in the tumor cells largely underlies the tumor-promoting effects of excess copper [34]. This evidence concerns the gene RYR1 and neoplasm.